Pfizer Scientist Dies

Genetics researcher and senior vice president of the pharmaceutical giant, David Cox, has passed away unexpectedly at age 66.

By | January 25, 2013

FLICKR, Montgomery County Planning CommissionThe head genetics researcher at Pfizer Corporation’s San Francisco office, David Cox, died unexpectedly, the company announced this week (January 22). He was 66 years old. Cox, a senior vice president who joined in the multinational pharmaceutical company in 2008, was considered a visionary leader in drug development and biotech innovations.

“David Cox was a world-renowned geneticist and a highly valued leader here at Pfizer,” a Pfizer spokeswoman said in a statement, reported by Forbes. “As the company’s lead geneticist based at our Rinat facility in San Francisco, David was a driving force in shaping Pfizer’s strategy on Precision Medicine, as well as our vision for the future of biomedical innovation. Our thoughts and sympathies are with David’s family during this difficult time, and he will be truly missed.”

Before joining Pfizer, Cox trained as a pediatrician and became professor of genetics and pediatrics at Stanford University as well as the co-director of the Stanford Genome Center. After being involved in the project to sequence the human genome, he went on to co-found and become the chief scientific officer of the personal genomics firm, Perlegen, which is now defunct.

Early reports did not include the cause of his death.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Scientists Activate Predatory Instinct in Mice
  2. Superbug Resistant to Every Antibiotic in the U.S. Killed Nevada Woman
  3. Next Generation: Mobile Microscope Detects DNA Sequences
  4. Tenure Under Attack in Two More States
    The Nutshell Tenure Under Attack in Two More States

    Proposed legislation would eliminate academic tenure at public universities in Iowa and Missouri, echoing a move that has already gutted such permanent posts in Wisconsin.

RayBiotech